Skip to main content
Veterinary Medicines

Avishield ND B1 + IB H120

Authorised
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
  • Newcastle disease virus, strain B1 Hitchner, Live

Product identification

Medicine name:
Avishield ND B1 + IB H120
Active substance:
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
  • Newcastle disease virus, strain B1 Hitchner, Live
Target species:
  • Chicken
Route of administration:
  • Oculonasal use
  • In drinking water use

Product details

Active substance and strength:
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
    4.50
    50% Embryo Infective Dose
    /
    1.00
    Dose
  • Newcastle disease virus, strain B1 Hitchner, Live
    7.00
    log10 tissue culture infective dose 50
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
  • Oculonasal use
    • Chicken
  • In drinking water use
    • Chicken
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD11
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:
  • The vaccine is filled into colourless glass vials (type I), which are closed with rubber stoppers (brombutyl) and sealed with aluminium caps. 1000 dose.
  • The vaccine is filled into colourless glass vials (type I), which are closed with rubber stoppers (brombutyl) and sealed with aluminium caps. 2500 dose.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Genera d.d.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Genera Istrazivanja d.o.o.
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
  • 3964/x/18 NÉBIH ÁTI
Date of authorisation status change:
Reference member state:
  • Hungary
Procedure number:
  • HU/V/0129/001
Concerned member states:
  • Croatia
  • Slovenia
How useful was this page?:
Average: 1 (2 votes)
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."